Britta Siegmund

from Wikipedia, the free encyclopedia

Britta Siegmund (born October 25, 1971 in Ehringshausen ) is a German doctor. She is a university professor at the Berlin Charité and clinical director of the Medical Clinic for Gastroenterology , Infectiology and Rheumatology there . In addition, she has been Vice President of the German Research Foundation since 2019 . Her research focus is on the research and treatment of chronic inflammatory bowel diseases such as Crohn's disease or ulcerative colitis .

Career

Britta Siegmund was born in Ehringshausen an der Lahn in 1971 and studied human medicine from 1992 to 1998 at the LMU Munich and - with a grant from the Harvard-Munich Alliance for Medical Education - at the Harvard Medical School in Boston. In her dissertation in 1998, she examined the anti-inflammatory effects of interleukin-10 in the synthesis of tumor necrosis factor . After her internship , she went to the University of Colorado in Denver from 2000 to 2002 as part of a DFG research grant .

Since her return to Germany, she has been working continuously at the Berlin University Hospital (Charité), initially in order to train as a specialist in internal medicine until 2007 . Here - at the Clinic for Gastroenterology, Infectiology, Rheumatology - as the leader of an Emmy Noether junior research group, she investigated the role of the hormone leptin in intestinal inflammation. In 2006 she completed her habilitation in "Experimental Medicine" and in the following year until 2012 she became a senior physician for internal medicine. In addition to her teaching license for experimental medicine, she also received it in 2009 for internal medicine. In 2012 she received a Heisenberg professorship in the field of translational gastroenterology and initially headed the clinic on an interim basis and from 2013 as W3 professor. Since 2016 she has also taken over the medical center management of the Charitè Centrum 13 for gastroenterology, nephrology , metabolic diseases .

Siegmund was elected to the German Academy of Sciences Leopoldina in 2017 and to the Berlin Brandenburg Academy of Sciences in 2019 . She was and is a member of the board of numerous medical organizations dealing with inflammatory bowel diseases, such as the chairwoman of the European Crohn's & Colitis Organization since 2016 and a board member of the German Society for Gastroenterology, Digestive and Metabolic Diseases since 2017 .

Within the German Research Foundation, she was involved as a member of the Medical Review Board from 2016 to 2017 and as a member of the Senate since 2018 before she was elected Vice President in mid-2019.

Publications (selection)

  • Regulation of tumor necrosis factor α synthesis by interleukin-10 and cAMP-increasing substances . (Dissertation). Munich 1998.
  • Effector phase of the intestinal immune response: regulation by interleukin-18 and leptin . (also dissertation, Berlin 2006). Berlin 2005, urn : nbn: de: kobv: 188-fudissthesis000000002507-9 ( online resource [accessed on February 9, 2020]).

Web links

Individual evidence

  1. a b c d DFG - German Research Foundation - Professor Dr. Britta Siegmund. Retrieved February 9, 2020 .
  2. a b c d Prof. Dr. Britta Siegmund Full member of the life sciences and medicine class. (PDF) In: bbaw.de. Berlin-Brandenburg Academy of Sciences, May 2019, accessed on February 9, 2020 .
  3. Britta Siegmund: Regulation of tumor necrosis factor α synthesis [tumor necrosis factor alpha synthesis] by interleukin-10 and cAMP-increasing substances . ( dnb.de [accessed on February 9, 2020]).
  4. a b Anjana Buckow: Flexible training models for the next generation in demand . In: Supplement to duz - the independent university magazine . RAABE specialist publisher for science information, Berlin February 22, 2008, p. 17 ( online at dfg.de [PDF]).
  5. a b Members - Prof. Dr. Britta Siegmund. In: leopoldina.org. Retrieved February 9, 2020 .
  6. Britta Siegmund. In: bbaw.de. Berlin-Brandenburg Academy of Sciences, accessed February 9, 2020 .